Tag: clinical_trial
-
Antiviral Drug Fails to Improve Long COVID Symptoms in NIH Trial
A clinical trial found a common antiviral drug given for up to 25 days did not improve Long COVID symptoms. Other NIH Research Matters studies cover cystic fibrosis tRNA treatment and C. difficile in newborn mice.
HealthScience & TechnologyMedical ScienceGeneral PoliticsFederal GovernmentUSA Long COVIDantiviral drugclinical trialcystic fibrosistransfer RNAC. difficileNIH Research Matters
-
Yale Launches Trial to Test Whether Adalimumab Can Halt Parkinson's Before It Starts
Yale researchers are testing adalimumab, already used for other conditions, in a new clinical trial that aims to slow or prevent Parkinson's disease during the decades-long window before motor symptoms appear.
HealthScience & TechnologyEducationMediaSportMedical ScienceAstronomy and SpaceFilm and TVSocial Issues Parkinson's diseaseadalimumabYale Universityclinical trialYale Jackson SchoolWindham-Campbell PrizesMaurie McInnisUniversity
-
Yale Researchers Launch Trial Aiming to Stop Parkinson's Disease Before It Starts
Yale researchers are testing whether adalimumab, already used for other conditions, can slow or prevent Parkinson's disease during the decades-long gap before motor symptoms appear.
HealthScience & TechnologyEntertainmentEducationMedical ScienceFinancial MarketsEnvironmentFilm and TV Parkinson's diseaseadalimumabYale Universityclinical trialRachel CarsonBeinecke Librarystock market researchUniversity
-
NIH Research Uncovers Advances in Allergy Treatment, Diabetes Risk, and Brain Disease Mechanisms
New research from NIH highlights potential treatments for peanut allergies, a link between endometriosis and type 2 diabetes risk, and a novel role for tau protein in brain diseases, advancing medical understanding.
HealthScience & TechnologyMedical ScienceSocial Issues Peanut AllergiesEndometriosisType 2 DiabetesBrain DiseasesMicrobiomeClinical TrialTau ProteinNIH RESEARCH MATTERS
-
Penn Medicine Launches First Human Trial for Advanced FLASH Proton Therapy
Penn Medicine begins the first human clinical trial for FLASH proton therapy, a faster, more powerful, and potentially less-toxic radiation treatment for cancer, aiming to improve patient quality of life.
HealthScience & TechnologySportMediaMedical ScienceAstronomy and SpaceEducationEnvironmentSocial Issues Penn MedicineFLASH proton therapycancer treatmentclinical trialradiation therapyAlexander LinOncology
-
Penn Medicine Launches First Human Trial for FLASH Proton Therapy
Penn Medicine has launched the first human clinical trial for FLASH proton therapy, a faster and potentially less-toxic radiation treatment for cancer. This innovative approach aims to improve patient outcomes and convenience.
HealthScience & TechnologyBusinessWorldMedical ScienceEnvironmentEconomyFinancial MarketsEducationSocial Issues Penn MedicineFLASH proton therapyCancer treatmentClinical trialRadiation therapyAlexander LinHealth & Medicine
-
Lifestyle Intervention Lowers Multimorbidity Risk in Prediabetes, NIH Study Finds
Lifestyle intervention significantly reduced the risk of developing multiple chronic conditions in adults with prediabetes over two decades, an NIH-supported trial found. Metformin did not show the same benefit, highlighting lasting advantages of healthy lifestyle programs.
HealthScience & TechnologyMedical ScienceFederal GovernmentEducation PrediabetesLifestyle InterventionMultimorbidityMetforminClinical TrialNational Institutes of Health (NIH)Chronic ConditionsNational Institutes of Health
-
Pioneering CAR T Cell Therapy Opens Doors for Kidney Transplant Patients
Penn Medicine's clinical trial uses CAR T cell therapy to enable kidney transplants for two end-stage patients, offering transformative hope for those on waiting lists.
HealthBusinessScience & TechnologyWeatherMedical ScienceArtificial IntelligenceEconomyReal EstateClimate ChangeEducation Penn MedicineCAR T cell therapyKidney transplantClinical trialAli NajiEnd-stage kidney diseaseMedical breakthrough
-
NIH Advances Experimental Opioid Use Disorder Treatment with Mitragynine Trial
NIH's Investigational New Drug application for mitragynine, a kratom compound, is now active, enabling a Phase I clinical trial. This study will assess the safety and tolerability of mitragynine as a potential new treatment for opioid use disorder, addressing high…
HealthScience & TechnologyMedical ScienceFederal GovernmentSocial Issues NIHOpioid Use DisorderMitragynineKratomClinical TrialFDADrug DevelopmentNational Institutes of Health
-
Media Monitor: Pancreatic Cancer Drug Shows Promising Clinical Trial Results
The Washington Post is reporting that a new pill, daraxonrasib, has shown promising results in a clinical trial for pancreatic cancer, doubling patient survival compared to standard chemotherapy.
HealthScience & TechnologyMedical Science DaraxonrasibClinical trialPancreatic cancerChemotherapyMedical researchDrug developmentThe Washington Post